AI in Action

Auto Added by WPeMatico

Banner for the AI & Big Data Expo event series.

Bunkerhill raises $55M to scale agentic AI across health systems

agentic ai, agents, ai, AI (Artificial Intelligence), AI in Action, AI Startups & Funding, Artificial Intelligence, clinical ai, digital health, Features, Funding, Governance, Regulation & Policy, Health, Healthcare, Healthcare & Wellness AI, medical, World of Work

Bunkerhill Health has raised $55 million to scale its agentic AI platform, Carebricks. The closing of the company’s Series B round, announced today, folds in continued participation from Sequoia Capital, Felicis, Optum Ventures, and Y Combinator. However, a funding total doesn’t answer the key question any hospital executive wants to know about healthcare AI: does […]

Bunkerhill raises $55M to scale agentic AI across health systems Read More »

Examining Google DeepMind’s AI bioresilience push

ai, AI (Artificial Intelligence), AI in Action, alphafold, Artificial Intelligence, bioresilience, biosecurity, Cybersecurity AI, Deep Dives, DeepMind, Diagnostics, dna synthesis, Featured News, Features, Gemini, Google, Governance, Regulation & Policy, Government & Public Sector AI, Healthcare & Wellness AI, How It Works, Isomorphic Labs, medical, metagenomics, pathogens, Policy, Red Teaming, SynthID

Google DeepMind and Isomorphic Labs outlined a bioresilience program to curb AI misuse in biology while aiding outbreak response. The two organisations published an update on a joint initiative that began quietly and has now built out more than 15 partnerships with government bodies, biosecurity organisations, and research groups over the past 12 months. The

Examining Google DeepMind’s AI bioresilience push Read More »

Banner for AI & Big Data Expo by TechEx events.

Neko Health raises $700 million to expand AI body scans in the US

ai, AI (Artificial Intelligence), AI in Action, AI regulation, AI Startups & Funding, Artificial Intelligence, Funding, governance, Governance, Regulation & Policy, Healthcare, Healthcare & Wellness AI, wellness

Neko Health has raised $700 million to expand its AI body scans in the United States, starting with a clinic in New York. The company’s preventive screening service combines medical imaging, blood tests, proprietary sensors, and clinician review. The Series C round was led by Lightspeed Venture Partners and co-led by O.G. Venture Partners. Existing

Neko Health raises $700 million to expand AI body scans in the US Read More »

AWS and Bluesight build AI for hospital 340B compliance

agentic ai, agents, ai, AI (Artificial Intelligence), AI Business Strategy, AI in Action, Amazon, Artificial Intelligence, aws, bluesight, Cloud Computing, Compliance, Data Engineering, Data Engineering & MLOps, Deep Dives, Featured News, Features, Governance, Regulation & Policy, Healthcare, Healthcare & Wellness AI, How It Works, Infrastructure & Hardware

AWS (Amazon Web Services) has explained how Bluesight developed Prism, an AI layer that connects hospital pharmacy and compliance data across its product suite. Prism Assistant for ControlCheck has reached general availability and operates across 20 health systems, according to AWS vendor statements. Meanwhile, a multi-product agent for 340B Group Purchasing Organisation (GPO) compliance remains

AWS and Bluesight build AI for hospital 340B compliance Read More »

AI agent crawlers now need permission. Here’s how to get it

agentic ai, ai, AI (Artificial Intelligence), AI agent crawlers, AI Business Strategy, AI in Action, Artificial Intelligence, Cloudflare, content licensing, Inside AI, Matthew Prince, publishers, web crawlers

AI agent crawlers, the bots that fetch pages in real time on behalf of a person waiting for an answer, will be blocked by default on a slice of the web from September 15 onwards. Cloudflare announced the change on July 1, and most of the coverage since then has focused on Google. The more useful part

AI agent crawlers now need permission. Here’s how to get it Read More »

AWS GraphRAG deployment cuts drug research cycles by 87%

ai, AI (Artificial Intelligence), AI Business Strategy, AI in Action, amazon web services, Artificial Intelligence, aws, bedrock, claude, Cloud Computing, Data Engineering, Data Engineering & MLOps, drug research, enterprise, Featured News, Features, GraphRAG, Healthcare, Healthcare & Wellness AI, How It Works, Infrastructure & Hardware, Inside AI, knowledge graph, Medicine, Natural Language Processing (NLP), neptune, NLP, World of Work

A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated proprietary databases into a unified and queryable knowledge graph. Historically, initial data gathering and screening phases took over six months per iteration, yielding a low five percent success rate. Crucial

AWS GraphRAG deployment cuts drug research cycles by 87% Read More »

NHS AI blood test could reduce invasive womb cancer checks

ai, AI (Artificial Intelligence), AI in Action, Artificial Intelligence, Features, Government & Public Sector AI, Healthcare & Wellness AI, Healthcare AI, Research, uk government, wellness

Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for checks after experiencing heavy bleeding. About 10,000 women are diagnosed with womb

NHS AI blood test could reduce invasive womb cancer checks Read More »

Insilico Medicine advances AI drug for IPF to Phase III trials

ai, AI (Artificial Intelligence), AI and Us, AI in Action, AI Market Trends, Artificial Intelligence, Deep Dives, Featured News, Features, Founders & Visionaries, Healthcare & Wellness AI, How It Works, Inside AI, Reinforcement Learning

Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients

Insilico Medicine advances AI drug for IPF to Phase III trials Read More »

L’Oreal, Mondelez, and Nestle use AI to speed product development

ai, AI (Artificial Intelligence), AI Business Strategy, AI in Action, Artificial Intelligence, business strategy, Features, Logistics, productivity, Retail & Logistics AI, retail operations

L’Oreal is using AI to shorten product development timelines and identify new uses for ingredients already present in its portfolio. The French cosmetics group has applied AI in its laboratories for the past four years, with Fabrice Megarbane, president of L’Oreal’s consumer products division, telling Reuters that the technology helps the company predict how molecules

L’Oreal, Mondelez, and Nestle use AI to speed product development Read More »

China’s AI companion rules: what Beijing is really going after

ai, AI (Artificial Intelligence), AI Agents, AI and Us, AI companions, AI in Action, AI policy, AI regulation, Alibaba, Artificial Intelligence, bytedance, china ai, China's AI companion rules, Cyberspace Administration of China, Doubao, Entertainment & Media, Generative AI, Governance, Regulation & Policy, Human-AI Relationships, Inside AI, qwen

An AI companion sounds dystopian, but it has become a common thread in the wider conversation about the perils of generative AI. What it refers to is essentially a conversational agent built to sustain an ongoing, personal relationship with a user, with the memory and steady persona that keep it consistent from one session to

China’s AI companion rules: what Beijing is really going after Read More »